Learn More
Apexbio Technology LLC GSK J2 1394854-52-4 10mM (in 1mL DMSO)

Supplier: Apexbio Technology LLC B56855.1
GSK J2 is an inactive stereoisomer compound used as an experimental negative control for the histone demethylases JMJD3 (KDM6B) and UTX (KDM6A) GSK J2 does not inhibit the enzymatic activity of JMJD3 and UTX JMJD3 and UTX catalyze demethylation of histone H3 lysine 27 trimethyl (H3K27me3) and dimethyl (H3K27me2) influencing chromatin structure and gene expression GSK J2 is applied in biological research to confirm target specificity and distinguish off-target effects related to JMJD3/UTX inhibition by GSK-J1
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.